The direct link between the scale of the weight loss and the risk is measurable in numbers: at more than 20 percent weight loss the alopecia rate rose to 5.3 percent, while at less than 20 percent it was only 2.5 percent
Typically, patients start noticing some weight reduction within the first few weeks
Injection site reactions rank as one of the less common side effects in the overall tirzepatide safety profile
Most formulations contain reduced glutathione in doses ranging from 600 mg to 1200 mg per session
Tirzepatide (Zepbound, Mounjaro), a dual GLP-1/GIP receptor agonist approved for adults, has not yet received adolescent approval
The injection itself takes less than one minute and can be given in the abdomen, thigh, or upper armareas with adequate subcutaneous fat tissue